rs140454570
Positions:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004393.6(DAG1):āc.268A>Cā(p.Ser90Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000675 in 1,614,176 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.000026 ( 0 hom., cov: 31)
Exomes š: 0.000072 ( 2 hom. )
Consequence
DAG1
NM_004393.6 missense
NM_004393.6 missense
Scores
1
7
11
Clinical Significance
Conservation
PhyloP100: 4.05
Genes affected
DAG1 (HGNC:2666): (dystroglycan 1) This gene encodes dystroglycan, a central component of dystrophin-glycoprotein complex that links the extracellular matrix and the cytoskeleton in the skeletal muscle. The encoded preproprotein undergoes O- and N-glycosylation, and proteolytic processing to generate alpha and beta subunits. Certain mutations in this gene are known to cause distinct forms of muscular dystrophy. Alternative splicing results in multiple transcript variants, all encoding the same protein. [provided by RefSeq, Nov 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.09343439).
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DAG1 | NM_004393.6 | c.268A>C | p.Ser90Arg | missense_variant | 2/3 | ENST00000308775.7 | NP_004384.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DAG1 | ENST00000308775.7 | c.268A>C | p.Ser90Arg | missense_variant | 2/3 | 1 | NM_004393.6 | ENSP00000312435.2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152180Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
4
AN:
152180
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000124 AC: 31AN: 250922Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135618
GnomAD3 exomes
AF:
AC:
31
AN:
250922
Hom.:
AF XY:
AC XY:
21
AN XY:
135618
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000718 AC: 105AN: 1461878Hom.: 2 Cov.: 74 AF XY: 0.0000990 AC XY: 72AN XY: 727236
GnomAD4 exome
AF:
AC:
105
AN:
1461878
Hom.:
Cov.:
74
AF XY:
AC XY:
72
AN XY:
727236
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152298Hom.: 0 Cov.: 31 AF XY: 0.0000537 AC XY: 4AN XY: 74470
GnomAD4 genome
AF:
AC:
4
AN:
152298
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
19
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 17, 2024 | The c.268A>C (p.S90R) alteration is located in exon 2 (coding exon 1) of the DAG1 gene. This alteration results from a A to C substitution at nucleotide position 268, causing the serine (S) at amino acid position 90 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 18, 2019 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
T;T;T;T;T;T;T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T;.;.;.;.;.;T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;.;L;L;L;L;L;.;.
PrimateAI
Benign
T
PROVEAN
Benign
N;D;N;N;N;N;N;N;D
REVEL
Uncertain
Sift
Benign
T;D;T;T;T;T;T;D;D
Sift4G
Uncertain
D;D;D;D;D;D;D;D;D
Polyphen
B;.;B;B;B;B;B;.;.
Vest4
MutPred
Loss of glycosylation at S90 (P = 0.03);Loss of glycosylation at S90 (P = 0.03);Loss of glycosylation at S90 (P = 0.03);Loss of glycosylation at S90 (P = 0.03);Loss of glycosylation at S90 (P = 0.03);Loss of glycosylation at S90 (P = 0.03);Loss of glycosylation at S90 (P = 0.03);Loss of glycosylation at S90 (P = 0.03);Loss of glycosylation at S90 (P = 0.03);
MVP
MPC
0.32
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at